Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.61 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.61 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | CASP7 | P55210 | 1/20 | 0.38 |
| ▸ | PDE4A | P27815 | 2/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.36 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | ANPEP | P15144 | 1/20 | 0.34 |
| ▸ | DPP4 | P27487 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23027200 | 0.86 | CSNK2A2 (0.47) | CSNK2A2CSNK2BCSNK2A1KDM4EHSD17B10 | |
| SCHEMBL23027286 | 0.81 | CSNK2A2 (0.41) | CSNK2A2CSNK2BCSNK2A1KDM4EKMT2A | |
| SCHEMBL24489348 | 0.81 | CSNK2A2 (0.41) | CSNK2A2CSNK2BCSNK2A1KDM4EKMT2A | |
| SCHEMBL19616745 | 0.76 | CSNK2A2 (1.00) | CSNK2A2CSNK2BCSNK2A1KDM4EHSD17B10 | |
| SCHEMBL17965689 | 0.76 | CSNK2A2 (0.36) | CSNK2A2CSNK2BCSNK2A1PDE4APDE4B | |
| SCHEMBL29697484 | 0.76 | CSNK2A2 (0.36) | CSNK2A2CSNK2BCSNK2A1PDE4APDE4B | |
| SCHEMBL24489465 | 0.71 | CSNK2A2 (0.32) | CSNK2A2CSNK2BCSNK2A1PDE4APDE4B | |
| SCHEMBL23027209 | 0.71 | CSNK2A2 (0.32) | CSNK2A2CSNK2BCSNK2A1PDE4APDE4B | |
| SCHEMBL6926420 | 0.68 | ALDH1A1 (0.44) | CSNK2BCSNK2A1ANPEPDPP4MAPT | |
| SCHEMBL125972 | 0.68 | LMNA (0.71) | KDM4EHSD17B10KMT2AGAACASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220177411-A1 | PRODUCTION METHOD FOR NITROGEN-CONTAINING FLUORINE-CONTAINING COMPOUND | AGC Inc. (JP) | 2022-06-09 | — | — | US | disclosed |
| WO-2021033649-A1 | PRODUCTION METHOD FOR NITROGEN-CONTAINING FLUORINE-CONTAINING COMPOUND | ＡＧＣ株式会社 | 2021-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220177411-A1 | PRODUCTION METHOD FOR NITROGEN-CONTAINING FLUORINE-CONTAINING COMPOUND | F3, RNF5, POF1B | CSNK2A2 2946/4885CSNK2B 2828/4885CSNK2A1 2869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.